141 related articles for article (PubMed ID: 33779723)
1. Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease.
Pérez-López N; Martín C; García B; Solís-Hernández MP; Rodríguez D; Alcalde I; Merayo J; Fernández-Vega I; Quirós LM
J Neuropathol Exp Neurol; 2021 Apr; 80(5):446-456. PubMed ID: 33779723
[TBL] [Abstract][Full Text] [Related]
2. Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains.
Lorente-Gea L; García B; Martín C; Ordiales H; García-Suárez O; Piña-Batista KM; Merayo-Lloves J; Quirós LM; Fernández-Vega I
J Neuropathol Exp Neurol; 2020 May; 79(5):474-483. PubMed ID: 32232475
[TBL] [Abstract][Full Text] [Related]
3. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
4. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
[TBL] [Abstract][Full Text] [Related]
5. Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease.
Su JH; Cummings BJ; Cotman CW
Neuroscience; 1992 Dec; 51(4):801-13. PubMed ID: 1488123
[TBL] [Abstract][Full Text] [Related]
6. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease.
Perlmutter LS; Chui HC; Saperia D; Athanikar J
Brain Res; 1990 Jan; 508(1):13-9. PubMed ID: 2140065
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
[TBL] [Abstract][Full Text] [Related]
8. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.
Bruinsma IB; te Riet L; Gevers T; ten Dam GB; van Kuppevelt TH; David G; Küsters B; de Waal RM; Verbeek MM
Acta Neuropathol; 2010 Feb; 119(2):211-20. PubMed ID: 19636575
[TBL] [Abstract][Full Text] [Related]
9. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction.
Maresh GA; Erezyilmaz D; Murry CE; Nochlin D; Snow AD
J Neurochem; 1996 Sep; 67(3):1132-44. PubMed ID: 8752120
[TBL] [Abstract][Full Text] [Related]
10. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.
Buée L; Hof PR; Bouras C; Delacourte A; Perl DP; Morrison JH; Fillit HM
Acta Neuropathol; 1994; 87(5):469-80. PubMed ID: 8059599
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
12. Nerve injury induces the expression of EXT2, a glycosyltransferase required for heparan sulfate synthesis.
Murakami K; Namikawa K; Shimizu T; Shirasawa T; Yoshida S; Kiyama H
Neuroscience; 2006 Sep; 141(4):1961-9. PubMed ID: 16784821
[TBL] [Abstract][Full Text] [Related]
13. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
Kisilevsky R; Szarek WA
J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
[TBL] [Abstract][Full Text] [Related]
15. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.
Crespo A; García-Suárez O; Fernández-Vega I; Solis-Hernandez MP; García B; Castañón S; Quirós LM
BMC Cancer; 2018 Jun; 18(1):687. PubMed ID: 29940912
[TBL] [Abstract][Full Text] [Related]
17. Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.
Verbeek MM; Otte-Höller I; van den Born J; van den Heuvel LP; David G; Wesseling P; de Waal RM
Am J Pathol; 1999 Dec; 155(6):2115-25. PubMed ID: 10595940
[TBL] [Abstract][Full Text] [Related]
18. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease.
Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596
[TBL] [Abstract][Full Text] [Related]
19. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces NO-dependent release of heparan sulfate in fibroblasts from the Alzheimer mouse Tg2576 by activation of nitrite reduction.
Cheng F; Bourseau-Guilmain E; Belting M; Fransson LÅ; Mani K
Glycobiology; 2016 Jun; 26(6):623-34. PubMed ID: 26791445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
